Infectious Disease Alert – October 1, 2003
October 1, 2003
View Archives Issues
-
Global HIV Perspective Suggests a Long Way to Go
The challenge facing the global community is to immediately marshall sufficient resources to ensure rapid scale-up of life-saving prevention strategies. Global HIV Prevention Working Group 2003 -
Neurotoxicity of Carbapenems
Carbapenems are a class of ß-lactam antibiotics that offer broad-spectrum therapy for patients with a variety of infections, including skin/skin structure, intra-abdominal, lower respiratory tract, meningitis, urinary tract, and bone/joint infections. -
Azithromycin as Single-Drug Therapy for Community-Acquired Pneumonia
Azithromycin is an effective, single-drug therapy for mild-to-moderate community-acquired pneumonia. -
Community-Acquired Methicillin-Resistant Staphylococcus aureus
Staphylococcus aureus is a versatile enemy. It is spreading in the community, as well as in the hospital, with increasing resistance to antibiotics. Its armamentarium now includes not only resistance to methicillin and vancomycin but also means of spread and pathogenic mechanisms we clearly need to know more aboutand soon. -
Updates
Management of Lipodystrophy in HIV: A Mini-Update; Yersiniosis Outbreak in Black Infants; Transfusion- Associated WNV -
Audio Conference
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Vardenafil Will Compete for Share of ED Market